Fig. 5From: Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbitsOxidative stress and inflammation markers. Plasma superoxide dismutase (SOD) (a), malonaldehyde (MDA) (b), oxidized low-density lipoprotein (ox-LDL) (c) and C-reactive protein (CRP) levels (d) were measured at 12 weeks. Data are expressed as the mean ± SEM, n = 8 or 10 for each group. *P < 0.05, **P < 0.01 vs. vehicle or statin treatment groupBack to article page